Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Redburn Partners Upgrades Morningstar to Buy

Redburn Partners analyst Russell Quelch upgrades Morningstar (NASDAQ:MORN) from Neutral to Buy.

byBenzinga Newsdesk

September 20, 2022

1 minute read

Redburn Partners analyst Russell Quelch upgrades Morningstar (NASDAQ:MORN) from Neutral to Buy.

Mersana Therapeutics Announces FDA Grant Of Orphan Drug Designation To XMT-2056 For The Treatment Of Gastric Cancer

By Benzinga Newsdesk

Today, 7:36 PM

Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical

MRSN

Cleveland Fed President Loretta Mester Says Need To See Several More Good Inflation Readings

By Benzinga Newsdesk

Today, 7:36 PM

- Reuters

SPY

RBC Capital Downgrades Union Pacific to Sector Perform, Lowers Price Target to $258

By Benzinga Newsdesk

Today, 7:36 PM

RBC Capital analyst Walter Spracklin downgrades Union Pacific (NYSE:UNP) from Outperform to Sector Perform and lowers the price target from $271 to $258.

UNP